# Bioelectronica Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioelectronica

- Industry: Biotechnology
- Headquarters: Reno, US
- Website: www.bioelectronica.com
- Latest round: Series A (Feb 8, 2021)
- Investors on record: 4

## About

Bioelectronica Corporation, based in the US, specializes in advanced biochemical assay platforms that leverage computer vision technology to enhance antibody discovery for various research applications.Founded in 2017 and headquartered in Reno, Nevada, Bioelectronica Corporation focuses on developing innovative solutions for antibody discovery. The company has executed 2 deals, with the most recent funding round occurring on February 8, 2021. Jianjun Sun serves as the CEO, bringing valuable experience to the company.Bioelectronica specializes in advanced biochemical assay platforms leveraging computer vision technology to enhance antibody discovery. Their core offerings include the Hypercell Single-Cell Sorting Platform®, which allows for precise sorting of cells to expedite research and development processes, and the AI-powered cloud-based AbFinderAI™, designed to streamline the identification and analysis of antibodies. These tools are particularly beneficial for researchers in pharmaceuticals, biotechnology, and academic institutions focused on immunology and related fields. The company targets markets in North America, Europe, and Asia, serving a diverse clientele that includes biotech firms, research laboratories, and academic organizations engaged in antibody development.Bioelectronica generates revenue through a combination of direct sales and subscription-based models for its flagship products, including the Hypercell Single-Cell Sorting Platform® and AbFinderAI™. Clients typically engage in transactions structured around annual subscriptions or one-time purchases, depending on their research needs. The pricing structure is designed to accommodate various customer scales, from small startups to large research institutions, with offerings tailored to ensure accessibility and flexibility in usage. Partnerships with research organizations further enhance revenue streams by facilitating collaborative projects that utilize Bioelectronica’s proprietary technologies.In February 2021, Bioelectronica Corporation raised an undisclosed amount in SERIES A funding, led by Proxima Ventures and Co-Win Ventures. The company intends to utilize this funding to expand its team and explore new applications of cell line development and antibody discovery for the Hypercell® platform. Future initiatives include the development of new products aimed at enhancing their service offerings and strategic plans for market expansion in specific regions, although no exact dates have been provided.

## Funding rounds

- Series A, Feb 8, 2021 — Co-Win Ventures, Proxima Ventures
- Seed, May 1, 2019 — Rising Tide, Intuitive Private Equity

## Investors

- Rising Tide — Seed
- Intuitive Private Equity (https://capitalatlas.ai/funds/intuitive-private-equity) — Seed
- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Series A
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A